跳至主要内容
临床试验/ISRCTN13881401
ISRCTN13881401已完成Unknown

Curcumin as an adjunctive treatment for irritability in children with autism spectrum disorder: a randomized, double-blind, placebo-controlled clinical trial

Roozbeh Hospital0 个研究点目标入组 60 人开始时间: 2023年11月23日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children aged 4–12 years
  • 2. Male or female
  • 3. Outpatients referred to clinic with probable autistic signs and symptoms and who meet the DSM-5 criteria

排除标准

  • 1. Concurrent prominent psychiatric disorder
  • 2. Preexisting medical conditions (in particular epileptic disorders and febrile seizures)
  • 3. Intellectual disability (IQ <70)
  • 4. History of drug or alcohol abuse
  • 5. History of tardive dyskinesia
  • 6. History of taking antipsychotic medication within 6 months prior to enrollment

研究者

发起方
Roozbeh Hospital

相似试验